Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Fallowfield

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 9, 2021
Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-AnalysisAnneli Andersson, Matt Kelly, Kento Imajo, et al.
Biomed Research International|July 13, 2017
Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance AngiographyNatasha McDonald, David M L Lilburn, Neil J Lachlan, et al.
World Journal of Gastroenterology|August 28, 2024
Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19Angus K Jacobs, Steven D Morley, Kay Samuel, et al.
Journal of Clinical Medicine|June 28, 2023
Metabolism of Acetaminophen by Enteric Epithelial Cells Mitigates Hepatocellular Toxicity In VitroKatie Morgan, Steven D Morley, Arslan K Raja, et al.
Gut|November 26, 2010
Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell responseYiannis N Kallis, Andrew J Robson, Jonathan A Fallowfield, et al.
Journal of Hepatology|February 12, 2014
Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes studyJoanne R Morling, Jonathan A Fallowfield, Indra N Guha, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 16, 2019
Coffee Consumption and Kidney Function: A Mendelian Randomization StudyOliver J Kennedy, Nicola Pirastu, Robin Poole, et al.
JHEP Reports : Innovation in Hepatology|August 11, 2020
Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver diseaseRohit Sinha, Khalida A Lockman, Natalie Z M Homer, et al.
Cell Stem Cell|May 25, 2026
Autologous macrophage therapy increases transplant-free survival in cirrhosis: Long-term follow-up of a phase 2 clinical trialPaul N Brennan, Alastair M Kilpatrick, Alison Glover, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2013
Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes studyJoanne R Morling, Jonathan A Fallowfield, Rachel M Williamson, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 9, 2021
Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-AnalysisAnneli Andersson, Matt Kelly, Kento Imajo, et al.
Biomed Research International|July 13, 2017
Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance AngiographyNatasha McDonald, David M L Lilburn, Neil J Lachlan, et al.
World Journal of Gastroenterology|August 28, 2024
Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19Angus K Jacobs, Steven D Morley, Kay Samuel, et al.
Journal of Clinical Medicine|June 28, 2023
Metabolism of Acetaminophen by Enteric Epithelial Cells Mitigates Hepatocellular Toxicity In VitroKatie Morgan, Steven D Morley, Arslan K Raja, et al.
Gut|November 26, 2010
Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell responseYiannis N Kallis, Andrew J Robson, Jonathan A Fallowfield, et al.
Journal of Hepatology|February 12, 2014
Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes studyJoanne R Morling, Jonathan A Fallowfield, Indra N Guha, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 16, 2019
Coffee Consumption and Kidney Function: A Mendelian Randomization StudyOliver J Kennedy, Nicola Pirastu, Robin Poole, et al.
JHEP Reports : Innovation in Hepatology|August 11, 2020
Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver diseaseRohit Sinha, Khalida A Lockman, Natalie Z M Homer, et al.
Cell Stem Cell|May 25, 2026
Autologous macrophage therapy increases transplant-free survival in cirrhosis: Long-term follow-up of a phase 2 clinical trialPaul N Brennan, Alastair M Kilpatrick, Alison Glover, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2013
Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes studyJoanne R Morling, Jonathan A Fallowfield, Rachel M Williamson, et al.
Pageof 7